Skip to main content

Anti-NMDA Receptor Encephalitis clinical trials at UCSF

1 research study open to eligible people

Anti-NMDA receptor encephalitis is a disease where the body's immune system attacks the brain. UCSF is studying a drug called Satralizumab to see if it helps people with this condition. The trial looks at how safe and effective the drug is for patients.

Showing trials for

Our lead scientists for Anti-NMDA Receptor Encephalitis research studies include .

Last updated: